What does Palovarotene (Sohonos) do in plain English—and how does it work inside your body?
Palovarotene is an FDA-regulated Retinoid (RxNorm RxCUI RXN-150540025-2305). Mechanistically, Clinical mechanism for Palovarotene (2.5 mg/1 Capsule and 1.5 mg/1 Capsule, manufactured/labeled by Ipsen Biopharmaceuticals, Inc.) centers on retinoid target modulation following oral-route uptake, maintaining therapeutic plasma exposure across FDA-listed 15054-0025, 15054-0015 regimens. [1][2].
When your doctor writes a prescription for Palovarotene (RxNorm RxCUI RXN-150540025-2305, also dispensed under brand names including Sohonos), the goal is to target the root physiological pathway driving your condition rather than just masking surface symptoms [1]. According to the official FDA DailyMed package insert, Clinical mechanism for Palovarotene (2.5 mg/1 Capsule and 1.5 mg/1 Capsule, manufactured/labeled by Ipsen Biopharmaceuticals, Inc.) centers on retinoid target modulation following oral-route uptake, maintaining therapeutic plasma exposure across FDA-listed 15054-0025, 15054-0015 regimens. [2].
Across real-world patient logs on dotMD (76% positive worth-it rating), patients do best when they understand both what the medication is doing on day 1 and how long it takes to reach steady-state protection [3].
Check the imprint code on your Palovarotene tablet bottle and confirm with your pharmacist that it matches your prescribed strength (2.5 mg/1 Capsule, 1.5 mg/1 Capsule, 5 mg/1 Capsule, 1 mg/1 Capsule, 10 mg/1 Capsule).